Item

Patients with deglobulization % (n)

Patients without deglobulization % (n)

P

Number

25.4 (40)

74.5 (117)

­ Average age (years)

41.57 ± 16.11

37.25 ± 16.11

­ Sex ratio M/F

1.22

1.34

0.7

­ Alcohol and tobacco intoxication

8.3 (3)

5.1 (6)

­ History of hypertension

11.1 (4)

14.5 (17)

0.782

­ History of diabetes

11.1 (4)

8.5 (10)

0.742

­ Heart disease

5.6 (2)

2.6 (3)

0.336

­ History of tuberculosis

8.3 (3)

6.8 (8)

0.721

­ Nephrotoxic plant

2.8 (1)

7.7 (9)

0.454

­ Systolic hypertension

45.7 (16)

39.7 (46)

0.560

­ Diastolic hypertension

37.1 (13)

28.4 (33)

0.402

­ Reduced diuresis

19.4 (7)

9.4 (11)

0.341

­ Hyperuremia

80.6 (29)

56.9 (66)

0.017

­ acute kidney injury

77.8 (12)

49.6 (58)

0.04

­ Leukocyturia

82.5 (33)

52.99 (62)

0.819

­ Hematuria

78.8 (26)

76.4 (81)

0.516

­ Hyperferritinemia

23.8 (5)

13.1 (8)

­ Hypoferritinemia

28.6 (6)

52.5 (32)

­ Increased CRP

47.2 (17)

33.6 (38)

0.167

­ Anemia

55.6 (20)

46.6 (54)

0.446

­ Hyperleukocytosis

37.1 (13)

29.3 (32)

0.888

­ Leukopenia

8.6 (6)

11.2 (13)

0.690

­ Thrombocytopenia

16.7 (6)

7.8 (9)

0.197

­ TP

2.8 (1)

6 (7)

0.681

­ Hypoalbuminemia

91.4 (32)

92.8 (103)

1

­ Hypocalcemia

58.8 (6)

66.3 (67)

0.535

­ Hyperphosphatemia

63.6 (21)

42.7 (38)

0.04

­ Hyperparathormonemia

80.8 (21)

71.8 (34)

0.441

­ Hyperuricemia

78.1 (25)

70.4 (4)

0.487

­ Hypercholesterolemia

52 (13)

46.7% (35)

0.818

­ Complementary C3 consumed

29 (9)

33.7 (34)

0.669

­ Complementary C4 consumed

22.6 (7)

22.6 (21)

1

­ Anti-nuclear antibodies

33.3 (8)

40 (28)

0.632

­ Anti DNA antibodies

27.3 (6)

31.7 (20)

0.792

­ ANCA

33.3 (4)

20 (6)

0.433

­ Reduced kidney size

17.2 (5)

10.5 (9)

0.513

­ Limited differentiation

17.2 (5)

16.3 (14)

0.554

­ Nephroprotective

65.7 (23)

61.4 (70)

0.694

­ Acute hemodialysis

24.7 (23)

78 (8)

0.02

­ Hemodialysis after PRB

11.4 (4)

6.5 (7)

0.465